International Journal of Endocrinology
Volume 2018 (2018), Article ID 6050369, 1 page
https://doi.org/10.1155/2018/6050369

Corrigendum

Corrigendum to “Myoinositol: The Bridge (PONTI) to Reach a Healthy Pregnancy”

Pietro Cavalli and Elena Ronda

Clinical Genetics, ASST Cremona, Via Concordia 1, 26100 Cremona, Italy

Correspondence should be addressed to Pietro Cavalli; p.cavalli@ospedale.cremona.it

Received 6 August 2018; Accepted 7 August 2018; Published 12 September 2018

Copyright © 2018 Pietro Cavalli and Elena Ronda. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

In the article titled “Myoinositol: The Bridge (PONTI) to Reach a Healthy Pregnancy” [1], the “Competing Interest” section should read as follows:

Conflicts of Interest

Publication was sponsored by LOLI Pharma SRL. This was not declared due to an oversight. The authors have no other personal or financial relationship with LOLI Pharma Company.

References

P. Cavalli and E. Ronda, “Myoinositol: the bridge (PONTI) to reach a healthy pregnancy,” International Journal of Endocrinology, vol. 2017, Article ID 5846286, 5 pages, 2017.